Navar AM - Search Results

1

The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees.

Navar AM, Khan SS, Patton KK, Day SM, Mehran R. Navar AM, et al. JAMA Cardiol. 2024 Oct 1;9(10):869-870. doi: 10.1001/jamacardio.2024.2318. JAMA Cardiol. 2024. PMID: 39110447 No abstract available.

2

Equity in Clinical Trial Participation Requires Equity in Identification and Treatment of Valvular Heart Disease.

Navar AM. Navar AM. JAMA Cardiol. 2023 Feb 1;8(2):128-129. doi: 10.1001/jamacardio.2022.4463. JAMA Cardiol. 2023. PMID: 36478024 No abstract available.

3

Prevalence, Awareness, and Treatment of Elevated LDL Cholesterol in US Adults, 1999-2020.

Sayed A, Navar AM, Slipczuk L, Ballantyne CM, Samad Z, Lavie CJ, Virani SS. Sayed A, et al. Among authors: navar am. JAMA Cardiol. 2023 Dec 1;8(12):1185-1187. doi: 10.1001/jamacardio.2023.3931. JAMA Cardiol. 2023. PMID: 37910086 Free PMC article.

4

Primary prevention statin therapy in older adults.

Nanna MG, Abdullah A, Mortensen MB, Navar AM. Nanna MG, et al. Among authors: navar am. Curr Opin Cardiol. 2023 Jan 1;38(1):11-20. doi: 10.1097/HCO.0000000000001003. Epub 2022 Nov 2. Curr Opin Cardiol. 2023. PMID: 36598445 Free PMC article. Review.

5

Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the Week.

Parsa S, Saleh A, Raygor V, Hoeting N, Rao A, Navar AM, Rohatgi A, Kay F, Abbara S, Khera A, Joshi PH. Parsa S, et al. Among authors: navar am. J Am Coll Cardiol. 2024 Apr 23;83(16):1557-1567. doi: 10.1016/j.jacc.2024.01.039. J Am Coll Cardiol. 2024. PMID: 38631775 Review.

6

Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events.

Mortensen MB, Jensen JM, Rønnow Sand NP, Kragholm K, Blaha MJ, Grove EL, Sørensen HT, Olesen K, Maeng M, Løgstrup B, Busk M, Hauge EM, Navar AM, Bøtker HE, Nørgaard BL. Mortensen MB, et al. Among authors: navar am. J Am Coll Cardiol. 2024 Jun 25;83(25):2643-2654. doi: 10.1016/j.jacc.2024.04.030. J Am Coll Cardiol. 2024. PMID: 38897674

7

Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial.

Nissen SE, Wang Q, Nicholls SJ, Navar AM, Ray KK, Schwartz GG, Szarek M, Stroes ESG, Troquay R, Dorresteijn JAN, Fok H, Rider DA, Romano S, Wolski K, Rambaran C. Nissen SE, et al. Among authors: navar am. JAMA. 2024 Nov 18:e2421957. doi: 10.1001/jama.2024.21957. Online ahead of print. JAMA. 2024. PMID: 39556769

8

Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.

Nicholls SJ, Ni W, Rhodes GM, Nissen SE, Navar AM, Michael LF, Haupt A, Krege JH. Nicholls SJ, et al. Among authors: navar am. JAMA. 2024 Nov 18:e2424017. doi: 10.1001/jama.2024.24017. Online ahead of print. JAMA. 2024. PMID: 39556768

9

Trends in Primary Aldosteronism Screening Among High-Risk Hypertensive Adults.

Kositanurit W, Giacona JM, Xie D, Wang J, Feuer D, O'Malley KJ, Navar AM, Vaidya A, Cohen JB, Vongpatanasin W. Kositanurit W, et al. Among authors: navar am. J Am Heart Assoc. 2024 Aug 6;13(15):e036373. doi: 10.1161/JAHA.124.036373. Epub 2024 Jul 31. J Am Heart Assoc. 2024. PMID: 39082409 Free article. No abstract available.

10

Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry.

Navar AM, Shah NP, Shrader P, Thomas LE, Ahmad Z, Allred C, Chamberlain AM, Chrischilles EA, Dhalwani N, Effron MB, Hayek S, Jones LK, Kalich B, Shapiro MD, Wójcik C, Peterson ED. Navar AM, et al. Am Heart J. 2024 Jul 6:S0002-8703(24)00165-0. doi: 10.1016/j.ahj.2024.06.012. Online ahead of print. Am Heart J. 2024. PMID: 38972336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters